3-Propoxy-4-(trimethylazaniumyl)butanoate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 3-Propoxy-4-(trimethylazaniumyl)butanoate
• 化学式: C10H21NO3
• 分子量: 203.28
• InChiKey: QPQUZRVOWMOFMX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  14
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  49.4
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• ANTIFATIGUE COMPOSITION
  申请人：Kaneka Corporation

  公开号：EP1747778A1

  公开（公告）日：2007-01-31

  Fatigue is significantly involved in the lifestyle of people today. Although many anti-fatigue products are on market, those with definite and reliable effects are still few. Under such circumstances, the inventors of the present invention have conducted studies aiming at providing a composition which exhibits a distinctive anti-fatigue effect, and consequently accomplished the present invention. The present invention provides an anti-fatigue composition containing reduced coenzyme Q and a carnitine derivative. By administering the anti-fatigue composition of the present invention to a mammal, anti-fatigue effects can be synergistically seen even at doses which are not effective when the components are individually used. According to the present invention, an anti-fatigue composition having a reliable effect can be provided.

  疲劳与当今人们的生活方式息息相关。尽管市场上有许多抗疲劳产品，但具有明确可靠效果的产品仍然很少。在这种情况下，本发明的发明者进行了研究，旨在提供一种具有独特抗疲劳效果的组合物，从而完成了本发明。本发明提供了一种含有还原型辅酶 Q 和肉碱衍生物的抗疲劳组合物。通过向哺乳动物施用本发明的抗疲劳组合物，可以协同产生抗疲劳效果，即使是在单独使用这些成分时无效的剂量下也是如此。根据本发明，可以提供一种效果可靠的抗疲劳组合物。
• Anti-Fatigue Composition
  申请人：Kishida Hideyuki

  公开号：US20070293572A1

  公开（公告）日：2007-12-20

  Fatigue is significantly involved in the lifestyle of people today. Although many anti-fatigue products are on market, those with definite and reliable effects are still few. Under such circumstances, the inventors of the present invention have conducted studies aiming at providing a composition which exhibits a distinctive anti-fatigue effect, and consequently accomplished the present invention. The present invention provides an anti-fatigue composition containing reduced coenzyme Q and a carnitine derivative. By administering the anti-fatigue composition of the present invention to a mammal, anti-fatigue effects can be synergistically seen even at doses which are not effective when the components are individually used. According to the present invention, an anti-fatigue composition having a reliable effect can be provided.